Drug used in RSV infection in children: (A) Rituximab, (B) Palivizumab, (C) none, (D) Omalizurnab
Answer is B. Palivizumab is a chimeric mouse-human monoclonal IgG antibody against human respiratory syncitial virus infection.Combined ribavarin-palivizumab therapy is being evaluated for immunosuppressed children with HRSV pneumonia. Ref:Harrison's medicine-19th edition,page no:1206.